Step by Stepa HemeOncBuddy patient portal

Dabigatran

Illustration: Dabigatran

Say it: dah-BIG-uh-tran · Brand names: Pradaxa

Dabigatran is a blood thinner capsule that helps prevent and treat harmful blood clots.

What it is

Your blood uses a protein called thrombin to form clots. Dabigatran blocks thrombin directly. This makes it harder for dangerous clots to form or grow.

Often used for

How you get it

It is a capsule you take by mouth, usually 2 times a day. You can take it with or without food. Small pellets are made for children. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

At home

Questions to ask

Side effect guides

Sources

Quick answers

What is Dabigatran?
Dabigatran is a blood thinner capsule that helps prevent and treat harmful blood clots. Brand names: Pradaxa.
What is Dabigatran used for?
treating blood clots in the legs or lungs, after a few days of a blood thinner shot; lowering the chance that blood clots come back; lowering the chance of stroke in people with an irregular heartbeat called atrial fibrillation; preventing clots after hip replacement surgery; blood clots in children.
How is Dabigatran given?
It is a capsule you take by mouth, usually 2 times a day. You can take it with or without food. Small pellets are made for children. Your schedule may be different.
What are the common side effects of Dabigatran?
Bruising more easily. Small bleeding, like from your gums or nose. Heavier periods. Upset stomach, heartburn, or belly pain. Indigestion.
When should I call my care team while taking Dabigatran?
Bleeding that will not stop, such as a nosebleed or a cut that keeps bleeding; Red, pink, or dark brown urine; Red or black stools that look like tar; Coughing up blood, or throwing up blood or something that looks like coffee grounds; A sudden bad headache, confusion, weakness, or trouble seeing or speaking; A fall or a hit to the head, even if you feel fine.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.